(Q40140188)

17 September 2017

Subclinical atherosclerosis in low Framingham risk HIV patients (English)

1 reference

17 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Sergio Reus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nicolás López

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Irene Portilla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

José Sánchez-Payá

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Livia Giner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Vicente Boix

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Esperanza Merino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Diego Torrús

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Óscar Moreno-Pérez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Joaquín Portilla

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

29 June 2017

1 reference

European Journal of Clinical Investigation

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

591-599

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

2 June 2020

cites work

1 reference

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

21 January 2018

1 reference

Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment

21 January 2018

1 reference

Microbial translocation and cardiometabolic risk factors in HIV infection

21 January 2018

1 reference

Microbial translocation in the pathogenesis of HIV infection and AIDS.

21 January 2018

1 reference

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

21 January 2018

1 reference

Plasma levels of soluble CD14 independently predict mortality in HIV infection

21 January 2018

1 reference

Carotid-wall intima-media thickness and cardiovascular events

21 January 2018

1 reference

Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view

21 January 2018

1 reference

Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection

21 January 2018

1 reference

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure

21 January 2018

1 reference

Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection

21 January 2018

1 reference

Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort

21 January 2018

1 reference

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection

21 January 2018

1 reference

Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation

21 January 2018

1 reference

A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.

21 January 2018

1 reference

Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case-control study

21 January 2018

1 reference

T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis

21 January 2018

1 reference

Associations between HIV infection and subclinical coronary atherosclerosis

21 January 2018

1 reference

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

21 January 2018

1 reference

Statins to improve cardiovascular outcomes in treated HIV infection

21 January 2018

1 reference

Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

21 January 2018

1 reference

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

21 January 2018

1 reference

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study

21 January 2018

1 reference

Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients

21 January 2018

1 reference

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

Arterial inflammation in patients with HIV.

21 January 2018

1 reference

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

21 January 2018

1 reference

Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care

21 January 2018

1 reference

Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals

21 January 2018

1 reference

Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s

21 January 2018

1 reference

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12780

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28664622%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference